FindTrial
Sign In

Oridonin induces garma-globin production in erythroid precursor cells from beta-thalassemic patients

Oridonin induces garma-globin production in erythroid precursor cells from beta-thalassemic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOB-16007883
Enrollment
Unknown
Registered
2016-02-02
Start date
2016-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beta-thalassemia

Interventions

experimental group :no
control group:no

Sponsors

Department of Neonatology, Guangdong Provincial Women and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) diagnosed as beta-thalassemia; 2) no blood transfusions for at least 3 months.

Exclusion criteria

Exclusion criteria: 1) current antianemic therapy; 2) poor treatment compliance

Design outcomes

Primary

MeasureTime frame
level of ?- globin gene;level of HbF;—

Countries

China

Contacts

Public ContactGuo Lishan
panny1982@163.com+86 13580538496

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026